Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Gongxiong Wu"'
Autor:
Jiyun Peng, Min-Hee Yi, Heejin Jeong, Przemyslaw Peter McEwan, Jiaying Zheng, Gongxiong Wu, Shashank Ganatra, Yi Ren, Jason R. Richardson, Seog Bae Oh, Long-Jun Wu
Publikováno v:
Molecular Brain, Vol 14, Iss 1, Pp 1-18 (2021)
Abstract Activation of spinal cord microglia contributes to the development of peripheral nerve injury-induced neuropathic pain. However, the molecular mechanisms underlying microglial function in neuropathic pain are not fully understood. We identif
Externí odkaz:
https://doaj.org/article/bc74ac4668b044a1a817f242f168918e
Autor:
Madhuvika Murugan, Jiaying Zheng, Gongxiong Wu, Rochelle Mogilevsky, Xin Zheng, Peiwen Hu, Junfang Wu, Long-Jun Wu
Publikováno v:
Molecular Brain, Vol 13, Iss 1, Pp 1-13 (2020)
Abstract Traumatic injury to the spinal cord initiates a series of pathological cellular processes that exacerbate tissue damage at and beyond the original site of injury. This secondary damage includes oxidative stress and inflammatory cascades that
Externí odkaz:
https://doaj.org/article/3cf91e85ccf5423a8bb6b1c3d19d2847
Autor:
Dale B. Bosco, Jiaying Zheng, Zhiyan Xu, Jiyun Peng, Ukpong B. Eyo, Ke Tang, Cheng Yan, Jun Huang, Lijie Feng, Gongxiong Wu, Jason R. Richardson, Hui Wang, Long-Jun Wu
Publikováno v:
Molecular Brain, Vol 11, Iss 1, Pp 1-13 (2018)
Abstract Microglia have been shown to be of critical importance to the progression of temporal lobe epilepsy. However, the broad transcriptional changes that these cells undergo following seizure induction is not well understood. As such, we utilized
Externí odkaz:
https://doaj.org/article/2edf870c16534658ade9b3a32465def5
Autor:
Bin He, Qianmin Yao, Zijing Liang, Junmin Lin, Yubao Xie, Shaoming Li, Gongxiong Wu, Zhihua Yang, Pingyi Xu
Publikováno v:
Cell Transplantation, Vol 25 (2016)
The therapeutic benefits of bone marrow-derived mesenchymal stem cell (BM-MSC) transplantation for ischemic stroke have been extensively demonstrated. However, studies on the optimal cell dose for intravenous administration are still limited. This st
Externí odkaz:
https://doaj.org/article/e70d09e007124a9687bb900369f85ca9
Autor:
Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu
Supplementary Figure 3 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02de62c9b041d44ac32c88fe3c7f9292
https://doi.org/10.1158/0008-5472.22390961
https://doi.org/10.1158/0008-5472.22390961
Autor:
Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu
Supplementary Materials and Methods from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9119103fa4899d70183c34f4dd03e0d2
https://doi.org/10.1158/0008-5472.22390946
https://doi.org/10.1158/0008-5472.22390946
Autor:
Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu
Supplementary Figure 5 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58060d593194ecbca325de2178189790
https://doi.org/10.1158/0008-5472.22390955.v1
https://doi.org/10.1158/0008-5472.22390955.v1
Autor:
Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu
Supplementary Figure 4 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7651fb5748c495a5d657c01d4d0a682e
https://doi.org/10.1158/0008-5472.22390958.v1
https://doi.org/10.1158/0008-5472.22390958.v1
Autor:
Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu
Rituximab efficacy in cancer therapy depends in part on induction of complement-dependent cytotoxicity (CDC). Human CD59 (hCD59) is a key complement regulatory protein that restricts the formation of the membrane attack complex, thereby inhibiting in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82ec89cf9b09ef241f2e8f9ef7f05fcb
https://doi.org/10.1158/0008-5472.c.6503108.v1
https://doi.org/10.1158/0008-5472.c.6503108.v1
Autor:
Pengyu Zong, jianlin feng, Zhichao Yue, Yunfeng Li, Gongxiong Wu, Baonan Sun, Yanlin He, Barbara Miller, Albert S Yu, Zhongping Su, Jia Xie, Yasuo Mori, Bing Hao, Lixia Yue
Publikováno v:
Circulation Research. 131
Introduction: Ischemic stroke caused a heavy burden on public health. NMDA receptor (NMDAR) mediated excitotoxicity was thought to be the culprit for neuronal death during ischemic stroke. However, NMDAR antagonists all failed to show protective effe